Web Analytics
Catalent to Acquire Gene Therapy Leader Paragon Bioservices Inc

Catalent to Acquire Gene Therapy Leader Paragon Bioservices Inc

<

Catalent to acquire gene therapy leader Paragon Bioservices, Inc. for $1.2 billion

Colleen Floreck, Paragon Communications +1 410 975 8708 [email protected]

Catalent Completes Acquisition of Gene Therapy Leader Paragon Bioservices, Inc. for $1.2 Billion

Download Full Size ...

Catalent to Acquire Gene Therapy Leader Paragon Bioservices, Inc. for $1.2 Billion | Business Wire

Catalent to acquire gene therapy leader Paragon Bioservices, Inc. for $1.2 billion

Catalent to acquire gene therapy leader Paragon Bioservices, Inc. for $1.2 billion

Catalent to Acquire Gene Therapy Leader, Paragon Bioservices, Inc.

Catalent's leadership ...

Gene therapies

... expansion of its strategic collaboration in manufacturing design and operation with gene therapy leader Sarepta Therapeutics - Paragon Bioservices, Inc.

Paragon BioServices

Will provide new expertise and capabilities in one of the fastest-growing areas of healthcare, positioning Catalent for accelerated long-term growth

... acquire leading gene therapy company Paragon Bioservices for $1.2 billion. ×. Expand. DNA

Catalent to buy Paragon Bioservices for $1.2 billion

Image for Chris Holmes' LinkedIn activity called News Announcement - Catalent Pharma Solutions has acquired

Catalent to buy gene therapy company Paragon Bioservices for $1.2bn

Paragon Biosciences Acquired By Catalent for $1.2 Billion

University of Maryland BioPark-based Paragon Bioservices will be acquired by contract drug manufacturer Catalent in a $1.2 billion deal, the companies said ...

Baltimore-based Paragon Biosevices to be acquired by Catalent Inc. for $1.2 billion - Baltimore Sun

Biotechnology firm Paragon Bioservices unveiled its new 150,000-square-foot commercial manufacturing facility in

Catalent jumps into 'transformative' gene therapy space with $1.2bn Paragon buy - BioProcess InternationalBioProcess International

two men in suits shaking hands with buildings in front of them

Catalent to Acquire Gene Therapy Leader Paragon Bioservices, Inc. for $1.2 Billion – Global Banking & Finance Review

Paragon Bioservices, Inc.

Catalent to buy Paragon Bioservices for $1.2 billion: WSJ | The Pharmaceutical Marketing Group

Catalent to acquire gene therapy leader Paragon Bioservices

MedCity News

Catalent Acquires Gene Therapy Leader Paragon Bioservices

merger & acquisition

... part of the Paragon success story. Reach out to our Talent Acquisition team at [email protected] to schedule a meeting on June 4 or 5.

N.J.-based Everest Technologies, Philly-based Wolfinger Forensics announce merger Catalent to acquire Paragon Bioservices for $1.2B

Check Also

Parallel Screening for Oral Delivery of Macromolecules | Catalent in 90 Seconds

To learn more about this exciting combination, visit us at BIO International June 3-6 in Philadelphia, PA. Ask about our “reaching new heights together” ...

Paragon Bioservices Celebrates Grand Opening of its World-Class Gene Therapy Biomanufacturing Facility

52 articles with Paragon BioServices, Inc. Top Life Science Companies Hiring Now in June

Be a part of our success story - check out more than 80 current openings at Paragon by visiting http://tinyurl.com/paragoncareers .pic.twitter.com/ ...

Catalent in 90 Seconds

Lyophilisation USA

Paragon Bioservices is a leading viral vector development and manufacturing partner for gene therapies. 1Q2019 Life Science Growth Announcements

Image for Carsten Henriksen's LinkedIn activity called Breaking News: Catalent Pharma Solutions to acquire gene

Catalent to Acquire Gene Therapy Leader, Paragon Bioservices, Inc. - Duration: 2 minutes, 34 seconds.

4 N.J. companies rank on DiversityInc's Top 50 for Diversity list Catalent to acquire Paragon Bioservices ...

Catalent to acquire gene therapy leader Paragon Bioservices, Inc. for $1.2 billion

CEO, Pete Buzy, addressing attendees at Paragon Bioservices Grand Opening ceremony

Precigen @Precigen

Biologics Network

Paragon Bioservices, Inc.

Solbright, M2M Spectrum merge to create Iota Communications Inc. Catalent to acquire Paragon Bioservices ...

Serving the chemical, life science, and laboratory worlds

INDUSTRY EVENTS

Manufacturing will be a major future differentiator between gene therapy companies, according to one expert.

0 replies 1 retweet 8 likes

Catalent to acquire gene therapy leader Paragon Bioservices, Inc. for $1.2 billion | Markets Insider

Catalent shares the passion to unlock the potential of your product, offering comprehensive solutions and superior technologies for oral, biologic, ...

YouTube Premium

Catalent completes tender offer for all outstanding shares of Juniper Pharmaceuticals

Federal judge blocks new Trump administration abortion rule

Paragon Bioservices, Inc. cover image

0 replies 0 retweets 1 like

Addressing Early Development Formulation Challenges to De-Risk Formulation Development

BIO

Top 12 Life Sciences Companies Hiring Now in 2019

Catalent to acquire gene therapy leader Paragon Bioservices, Inc. for $1.2 billion - Bloomberg

Catalent to acquire Paragon Bioservices for $1.2B GoFundMe scandal with homeless vet hurts wide range of people, organizations

0 replies 0 retweets 6 likes

Blog

Catalent's Paragon plans second plant to support Sarepta pipeline - BioProcess InternationalBioProcess International

See all of our locations

Baltimore's Gemstone Biotherapeutics Poised to Transform Wound Care Market

quotient logo

Orphan Drugs

Catalent At CPhI North America

Aris Melissaratos - 2018 Distinguished Grand Champion of Maryland Manufacturing

25 Up-and-Coming Gene Therapies of 2019

Comparator and Marketed Drug Sourcing Solutions | Catalent in 90 Seconds

INDUSTRY EVENTS

Catalent to buy Paragon for $1.2B - reports

Vantage announces sale of Gateway Plaza in W. Deptford. PSEG acquires 6th N.C. solar farm · Catalent to acquire Paragon Bioservices ...

Manufacturing Advanced Therapies in Europe

Catalent to Acquire Cook Pharmica, for $950M

Gene Therapy Leaders Urge Global Moratorium on Germline Editing

Camden Partners Portfolio Company: Calvert Education Services

UMB startup CoapTech receives FDA clearance for feeding tube placement device

Catalent to acquire gene therapy leader Paragon Bioservices, Inc. for $1.2 billion | Nachricht | finanzen.net

Image for Jim Adams, CPSM'S LinkedIn activity called Congratulations to Paragon Bioservices, Inc.